Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Search research articles

Related Experiment Videos

Giant cell myocarditis.

M S Wilson, R F Barth, P B Baker

The American Journal of Medicine

|November 1, 1985

Summary

This summary is machine-generated.

Giant cell myocarditis is a rare, fatal heart condition. This case report suggests cyclosporine may offer a potential treatment by targeting immune responses involved in the disease.

Related Experiment Videos

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

"What if I'm not trans enough? What if I'm not man enough?": Transgender young adults' experiences of gender-affirming healthcare readiness assessments in Aotearoa New Zealand.

International journal of transgender health·2023

Same author

Indications and outcomes for repeat cytoreductive surgery and heated intra-peritoneal chemotherapy in peritoneal surface malignancy.

Surgical oncology·2021

Same author

Long-term outcomes for patients with peritoneal acellular mucinosis secondary to low grade appendiceal mucinous neoplasms.

European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology·2020

Same author

MicroRNA-mediated regulation of immune responses to intestinal helminth infections.

Parasite immunology·2016

Same author

CD4<sup>+</sup> Th2 cells are directly regulated by IL-10 during allergic airway inflammation.

Mucosal immunology·2016

Same author

IL-4-producing ILC2s are required for the differentiation of T<sub>H</sub>2 cells following Heligmosomoides polygyrus infection.

Mucosal immunology·2016

Same journal

GLP-1 Receptor Agonists and Age-related Macular Degeneration Risk in Diabetes or Non-diabetic Obesity: A Retrospective Cohort Study.

The American journal of medicine·2026

Same journal

Marijuana Use and Acute Myocardial Infarction: Mechanistic Insights, Clinical Implications, and Emerging Challenges.

The American journal of medicine·2026

Same journal

Cave Canem - Beware of the Dog.

The American journal of medicine·2026

Same journal

Risk Factors for 30-day Hospital Readmission After Hospital-at-Home Treatment of Acute Pyelonephritis.

The American journal of medicine·2026

Same journal

Mesenteric Panniculitis.

The American journal of medicine·2026

Same journal

Hypercalcemia and hyperferritinemia in a patient with Graves' disease disease.

The American journal of medicine·2026

See all related articles

Area of Science:

Cardiology
Immunology
Pathology

Background:

Giant cell myocarditis is a rare and often fatal inflammatory heart disease.
Diagnosis can be challenging, and treatment options are limited.

Observation:

A 45-year-old man with giant cell myocarditis died eight months after symptom onset.
Postmortem examination revealed extensive myocardial fibrosis and multinucleated giant cells in the heart.
Other organs, including lungs and lymph nodes, showed no granulomatous disease, ruling out sarcoidosis.

Findings:

Histopathology suggests a role for cellular immune mechanisms in the pathogenesis of giant cell myocarditis.
The disease is suspected to have an autoimmune origin.

Implications:

Cyclosporine, an inhibitor of T lymphocyte responses, is proposed as a potential therapeutic agent.
This finding may open new avenues for treating this previously fatal condition.